Abstract
MUCH attention is being given to the effect of gonadal hormones on various biochemical events in the cell nuclei of the target tissues1–7. It is not known whether steroids act directly at nuclear sites; oestradiol-17β seems to associate with nuclear components without alteration of the oestrogen molecule8,9. Ventral prostate can retain androgens to a somewhat greater extent than the blood10,11, but studying the method of androgen retention is complicated by the rapid and multiple transformations of androgens injected into the experimental animals10–12. Consequently, we have asked two simple questions: (1) which metabolite(s) of testosterone can associate with isolated prostatic nuclei; and (2) is such association selective ? The results reported in this paper suggest to us that nuclear chromatin of prostate, but not other tissues which are insensitive to androgen, contains an androgen receptor which can selectively retain dihydrotestosterone (DHT, 5α-androstane-17β-ol-3-one)—the most potent endogenous androgen for the growth of ventral prostate of rat13,14.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Williams-Ashman, H. G., Cancer Res., 25, 1096 (1965).
Gorski, J., J. Biol. Chem., 239, 889 (1964).
Wilson, J. D., and Loeb, P. M., in Developmental and Metabolic Control Mechanism and Neoplasia, 375 (Williams and Wilkins Co., Baltimore, 1965).
Barton, R. W., and Liao, S., Endocrinology, 81, 409 (1967).
Liao, S., Barton, R. W., and Lin, A. H., Proc. US Nat. Acad. Sci., 55, 1593 (1966).
Liao, S., and Lin, A. H., Proc. US Nat. Acad. Sci., 57, 379 (1967).
Ritter, C., Mol. Pharmacol., 2, 125 (1966).
Jensen, E. V., Suzuki, T., Kawashima, T., Stumpf, W. E., Jungblut, P. W., and DeSombre, E. R., Proc. US Nat. Acad. Sci., 59, 632 (1968).
Maurer, H. R., and Chalkley, G. R., J. Mol. Biol., 27, 431 (1967).
Pearlman, W. H., US Nat. Cancer Inst. Monog. No. 12, 309 (1963).
Harding, B. W., and Samuels, L. T., Endocrinology, 70, 109 (1962).
Farnsworth, W. E., and Brown, J. R., US Nat. Cancer Inst. Monog. No. 12, 323 (1963).
Huggins, C., and Mainzer, K., J. Exp. Med., 105, 485 (1957).
Saunders, F. J., US Nat. Cancer Inst. Monog. No. 12, 1139 (1964).
Bruchovsky, N., and Wilson, J. D., Clin. Res., 14, 74 (1968).
Liao, S., Leininger, K. R., Sagher, D., and Barton, R. W., Endocrinology, 77, 763 (1965).
Chauveau, J., Moule, Y., and Royiller, C., Exp. Cell Res., 11, 317 (1956).
Shimazaki, J., Kurihara, H., Ito, Y., and Shida, K., Gunma J. Med. Sci., 14, 326 (1965).
Davidson, S. J., and Talalay, P., J. Biol. Chem., 241, 906 (1966).
Sluyser, M., J. Mol. Biol., 22, 411 (1966).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
ANDERSON, K., LIAO, S. Selective Retention of Dihydrotestosterone by Prostatic Nuclei. Nature 219, 277–279 (1968). https://doi.org/10.1038/219277a0
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1038/219277a0
This article is cited by
-
The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications
Nature Reviews Urology (2023)
-
Prostate cancer and therapeutic challenges
Journal of Biological Research-Thessaloniki (2020)
-
Evolution of androgen receptor targeted therapy for advanced prostate cancer
Nature Reviews Clinical Oncology (2014)
-
Novel drugs targeting the androgen receptor pathway in prostate cancer
Cancer and Metastasis Reviews (2014)
-
Molecular docking simulation studies on potent butyrylcholinesterase inhibitors obtained from microbial transformation of dihydrotestosterone
Chemistry Central Journal (2013)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.